Drug details

Tykerb (lapatinib)

type of Antineoplastic Tyrosine Kinase Inhibitors, Antineoplastics EGFR Inhibitors, Antineoplastics, Anti-HER2

Tykerb (lapatinib) is a cancer medication used together with another medicine called capecitabine (Xeloda) to treat a certain type of advanced breast cancer that has spread to other parts of the body, and is usually given after other cancer medications have been tried without successful treatment of symptoms.

This drug may have the following side effects:

• nausea,
• vomiting,
• mouth sores,
• upset stomach,
• rash,
• hair loss,
• dry skin,
• trouble sleeping.
• pain or redness on the palms of your hands or soles of your feet,
• problems with your fingernails or toenails, and

The following drugs are related to Tykerb, either as a replacement or used together:

• Alecensa (alectinib capsules)
• Arimidex (anastrozole)
• Aredia (pamidronate disodium)
• Aromasin (exemestane)
• Xeloda (capecitabine)
• Cytoxan (cyclophosphamide)
• Docefrez (docetaxel)
• Orserdu (elacestrant tablets)
• Ellence (epirubicin hydrochloride)
• Enhertu (fam-trastuzumab deruxtecan-nxki for injection)
• Fareston (toremifene)
• Femara (letrozole)
• Herzuma (trastuzumab-pkrb for injection)
• Ibrance (palbociclib capsules for oral administration)
• Nolvadex (tamoxifen citrate)
• Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf injection)
• Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)
• Soltamox (tamoxifen citrate)
• Talzenna (talazoparib capsules)
• Tukysa (tucatinib tablets)